Schwartz Kira M. 4
4 · Prevail Therapeutics Inc. · Filed Jun 3, 2020
Insider Transaction Report
Form 4
Schwartz Kira M.
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-06-02+100,000→ 100,000 totalExercise: $16.68Exp: 2030-06-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the Option shall vest on June 1, 2021; the remaining shares shall vest as to 1/36th of the shares monthly thereafter beginning on July 1, 2021, provided that the Reporting Person provides continuous service to the Issuer as of each such date.